T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 4.57 USD -0.65% Market Closed
Market Cap: 172.9m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one TLSI stock under the Base Case scenario is 8.59 USD. Compared to the current market price of 4.57 USD, TriSalus Life Sciences Inc is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLSI Relative Value
Base Case
8.59 USD
Undervaluation 47%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

4.5
P/S
P/S
Price to Sales
4.5
vs History
45
vs Industry
28
Median 3Y
5.2
Median 5Y
0
Industry
2
Forward
3.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
4
Median 3Y
-4
Median 5Y
-4.4
Industry
17.4
Forward
-5.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-128.2
Industry
10.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-18.9
Median 5Y
-214.9
Industry
13.4
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
3
Median 3Y
-5.7
Median 5Y
1.6
Industry
1.6
More Details
5
EV/S
EV/S
Enterprise Value to Sales
5
vs History
43
vs Industry
30
Median 3Y
5.5
Median 5Y
0
Industry
3
Forward
4.2
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
43
vs Industry
39
Median 3Y
6.5
Median 5Y
0
Industry
6.5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-109.3
Industry
10.7
Forward
-21.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-109.3
Industry
12.9
Forward
-10.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-128.2
Industry
11.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-128.2
Industry
12.1
More Details
14.9
EV/IC
EV/IC
Enterprise Value to IC
14.9
vs History
43
vs Industry
9
Median 3Y
16.5
Median 5Y
14
Industry
1.6
More Details

Multiples Across Competitors

TLSI Competitors Multiples
TriSalus Life Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
TriSalus Life Sciences Inc
NASDAQ:TLSI
172.9m USD 4.5 -3.9 -4.5 -4.4
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
IN
GTV Engineering Ltd
BSE:539479
45.7T INR 3.2 30.1 282 449 298 278.3
US
GE Vernova LLC
NYSE:GEV
154.5B USD 0 0 0 0
MY
Malton Bhd
KLSE:MALTON
485.7B MYR 941.9 17 083.1 6 406.4 6 892.1
US
China Industrial Group Inc
OTC:CIND
100.8B USD 293 3 350.6 2 847.8 2 947.7
NL
Nepi Rockcastle NV
JSE:NRP
83.8B Zac 0 0 0 0
US
CoreWeave Inc
NASDAQ:CRWV
61B USD 0 0 0 0
US
Coupang Inc
F:788
49.1B EUR 1.8 224.1 52.3 96
US
Circle Internet Group Inc
NYSE:CRCL
48.1B USD 0 0 0 0
CH
Galderma Group AG
SIX:GALD
30B CHF 0 0 0 0
P/S Multiple
Revenue Growth P/S to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average P/S: 248.9
4.5
52%
0.1
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
3.2
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
9%
N/A
MY
M
Malton Bhd
KLSE:MALTON
941.9
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
293
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-4%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
1.8
14%
0.1
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available
31%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
14%
N/A
P/E Multiple
Earnings Growth PEG
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average P/E: 5 172
Negative Multiple: -3.9 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
30.1
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
42%
N/A
MY
M
Malton Bhd
KLSE:MALTON
17 083.1
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 350.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
224.1
129%
1.7
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available
52%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
75%
N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average EV/EBITDA: 72 938.9
Negative Multiple: -4.5 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
282 449
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
44%
N/A
MY
M
Malton Bhd
KLSE:MALTON
6 406.4
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
2 847.8
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
7%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
143%
N/A
US
Coupang Inc
F:788
52.3
55%
1
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
23%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average EV/EBIT: 77 053.5
Negative Multiple: -4.4 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
IN
G
GTV Engineering Ltd
BSE:539479
298 278.3
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
80%
N/A
MY
M
Malton Bhd
KLSE:MALTON
6 892.1
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
2 947.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
11%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
96
77%
1.2
US
C
Circle Internet Group Inc
NYSE:CRCL
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
34%
N/A

See Also

Summary
TLSI intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLSI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLSI stock valuation using valuation multiples.
Wall Street Estimates
TLSI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLSI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 269,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.